Garrison Asset Management’s Novo Nordisk NVO Stock Holding History

Garrison Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.32M	Sell	11,050 -425	-4%	-$56.7K	0.67%	49
2024 Q2	$1.64M	Sell	11,475 -517	-4%	-$68.5K	0.86%	48
2024 Q1	$1.54M	Sell	11,992 -47	-0.4%	-$5.59K	0.81%	47
2023 Q4	$1.25M	Sell	12,039 -236	-2%	-$23.3K	0.69%	48
2023 Q3	$1.12M	Sell	12,275 -35	-0.3%	-$3.08K	0.68%	48
2023 Q2	$996K	Buy	12,310 +340	+3%	+$27.8K	0.6%	47
2023 Q1	$952K	Sell	11,970 -180	-1%	-$12.8K	0.59%	49
2022 Q4	$822K	Hold	12,150	–	–	0.53%	52
2022 Q3	$605K	Sell	12,150 -344	-3%	-$18.4K	0.43%	56
2022 Q2	$696K	Sell	12,494 -412	-3%	-$22.9K	0.47%	54
2022 Q1	$717K	Buy	12,906 +84	+0.7%	+$4.31K	0.4%	55
2021 Q4	$718K	Sell	12,822 -1,930	-13%	-$105K	0.39%	56
2021 Q3	$708K	Sell	14,752 -150	-1%	-$7.25K	0.43%	55
2021 Q2	$624K	Sell	14,902 -1,398	-9%	-$54.2K	0.38%	57
2021 Q1	$549K	Buy	16,300 +1,800	+12%	+$64.1K	0.35%	58
2020 Q4	$506K	Sell	14,500 -8,830	-38%	-$305K	0.35%	55
2020 Q3	$810K	Hold	23,330	–	–	0.43%	52
2020 Q2	$764K	Sell	23,330 -970	-4%	-$31K	0.43%	52
2020 Q1	$731K	Sell	24,300 -1,390	-5%	-$41.4K	0.49%	47
2019 Q4	$743K	Buy	25,690 +670	+3%	+$18.6K	0.37%	55
2019 Q3	$647K	Hold	25,020	–	–	0.34%	57
2019 Q2	$639K	Hold	25,020	–	–	0.33%	59
2019 Q1	$654K	Hold	25,020	–	–	0.35%	59
2018 Q4	$576K	Buy	25,020 +600	+2%	+$13.3K	0.34%	61
2018 Q3	$576K	Hold	24,420	–	–	0.29%	64
2018 Q2	$563K	Hold	24,420	–	–	0.28%	63
2018 Q1	$601K	Hold	24,420	–	–	0.34%	56
2017 Q4	$655K	Buy	24,420 +1,220	+5%	+$31K	0.34%	57
2017 Q3	$559K	Sell	23,200 -150	-0.6%	-$3.39K	0.31%	63
2017 Q2	$501K	Buy	23,350 +290	+1%	+$5.85K	0.29%	62
2017 Q1	$395K	Hold	23,060	–	–	0.23%	71
2016 Q4	$413K	Sell	23,060 -240	-1%	-$4.35K	0.26%	68
2016 Q3	$485K	Buy	23,300 +1,400	+6%	+$34.7K	0.31%	62
2016 Q2	$589K	Sell	21,900 -350	-2%	-$9.6K	0.39%	55
2016 Q1	$603K	Sell	22,250 -400	-2%	-$10.7K	0.42%	54
2015 Q4	$658K	Hold	22,650	–	–	0.45%	52
2015 Q3	$614K	Hold	22,650	–	–	0.45%	53
2015 Q2	$620K	Buy	22,650 +1,060	+5%	+$29.8K	0.42%	54
2015 Q1	$576K	Buy	21,590 +1,000	+5%	+$23K	0.38%	56
2014 Q4	$490K	Hold	20,590	–	–	0.37%	57
2014 Q3	$490K	Buy	20,590 +130	+0.6%	+$2.99K	0.37%	57
2014 Q2	$473K	Buy	20,460 +550	+3%	+$12.1K	0.34%	58
2014 Q1	$454K	Buy	19,910 +640	+3%	+$13.6K	0.35%	56
2013 Q4	$356K	Buy	19,270 +500	+3%	+$8.71K	0.29%	58
2013 Q3	$318K	Hold	18,770	–	–	0.28%	58
2013 Q2	$291K	Buy	+18,770	New	+$312K	0.27%	62

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Garrison Asset Management's NVO Position: Q3 2024 in Review

Garrison Asset Management reduced its Novo Nordisk (NVO) stake by 3.7% in Q3 2024, selling an estimated $56.7K and leaving 11,050 shares worth $1.32M. The position accounts for 0.67% of the portfolio, ranked #49.

Garrison Asset Management first reported a position in NVO in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.64M in Q2 2024. 1,786 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

Garrison Asset Management held 11,050 shares of Novo Nordisk worth $1.32M as of Q3 2024.
Garrison Asset Management sold 425 Novo Nordisk shares in Q3 2024, an estimated $56.7K.
Novo Nordisk made up 0.67% of Garrison Asset Management's portfolio in Q3 2024, its #49 holding.
Garrison Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 46 quarters since.
Garrison Asset Management's Novo Nordisk position peaked at $1.64M in Q2 2024.
1,786 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Garrison Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.